Akiram Therapeutics AB
559338-7458ActivePioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
Overview
- 1–4
- Employees
- 200–299K SEK
- Revenue
- 2021
- Founded
Key Decision Makers
Marika Nestor
Chief Executive Officer and Co-Founder
Anna Törner
Board Member
Peder Walberg
Board Member
Peter Frank
Chief Development Officer
+4 more contacts in Funnelfeedr
Description
Akiram Therapeutics is an emerging Swedish biotechnology company dedicated to revolutionizing cancer treatment. They specialize in developing innovative, targeted radioimmunotherapy designed to treat solid tumors, particularly metastatic cancers. Their proprietary approach combines radioactive molec...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Tillverkning av läkemedel
- Legal Form
- Aktiebolag
- VAT Number
- SE559338745801
Decision Makers
8 contacts in FunnelfeedrMarika Nestor
Chief Executive Officer and Co-Founder
Anna Törner
Board Member
Peder Walberg
Board Member
Peter Frank
Chief Development Officer
Fredrik Frejd
Chief Strategy Officer and Co-founder
Anja Mortensen
Chief Technology Officer and Co-founder
Tina Furebring
Project Management / Operations
Other Contacts
Jan Zedenius
Clinical Advisor
Similar Companies
20 similar companies in FunnelfeedrAcrivon AB
10–19 employeesDeveloping targeted cancer therapies using proprietary proteomics platform.
SACRA Therapeutics AB
0 employeesSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Affibody AB
50–99 employeesDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
AAX Biotech AB
5–9 employeesResearch-driven biotech advancing antibody therapies via proprietary technology.
CANTARGIA AB
20–49 employeesDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
Browse More
Akiram Therapeutics AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo